This study demonstrates that when cysteine intake is restricted, cysteine is heavily used for protein synthesis, which triggers ferroptosis and can significantly inhibit terminal neuroblastoma, suggesting that the high dependence of MYCN-driven brain tumor cells on cysteine is a novel therapeutic avenue that can be exploited to induce ferroptosis in cancer cells. The gene discussed is MYCN; the disease is cancer.